Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 8—August 2004

Group G Streptococcal Bacteremia in Jerusalem

Ronit Cohen-Poradosu*, Joseph Jaffe*, David Lavi*, Sigal Grisariu-Greenzaid*, Ran Nir-Paz*, Lea Valinsky†, Mary Dan-Goor†, Colin Block*, Bernard Beall‡, and Allon E. Moses*Comments to Author 
Author affiliations: *Hadassah-Hebrew University Medical Center, Jerusalem, Israel; †Ministry of Health Central Laboratory, Jerusalem, Israel; †Hebrew University-Hadassah Medical School, Jerusalem, Israel; ‡Centers for Disease Control and Prevention, Atlanta, GA, USA

Main Article

Table 1

Summary of clinical characteristic of 94 patients with group G streptococcal bacteremia

Characteristic No. of patients (%)
Age (y)

3 (3.1)
28 (29.8)
42 (44.7)
21 (22.3)
   Median (range)
62 (2–92)
51 (54.2)
Median LOHa in days
Underlying disorder

      Diabetes mellitus
33 (35.1)
33 (35.1)
18 (19.1)
      No disease
8 (8.5)
Type of infection

56 (59.6)
      Primary bacteremia
18 (19.1)
      Soft-tissue infectionb
4 (4.3)
      Bone and joint
4 (4.3)
3 (3.1)
3 (3.1)
1 (1.1)
      Line sepsis
1 (1.1)
4 (4.3)
Death rate 5 (5.3)

aLOH, length of hospitalization.
bSoft tissue infection, pressure sore attributable to diabetes

Main Article

Page created: March 01, 2011
Page updated: March 01, 2011
Page reviewed: March 01, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.